Neurocrine Biosciences | NBIX - Ebit





Ebit Cambio Fecha
AbbVie USD 6.88B 156M 2026-09
Acadia Pharmaceuticals USD 71.72M 33.88M 2026-09
Agios Pharmaceuticals USD -110.55M 527K 2026-06
ALKERMES USD 36.59M 102.52M 2026-09
Alnylam Pharmaceuticals USD 179.66M 67.06M 2026-09
Amgen USD 4.68B 65M 2026-09
Biogen USD 419.5M 663.3M 2026-09
BioMarin Pharmaceutical USD 205.6M 100M 2026-09
Cytokinetics USD -167.09M 12.08M 2026-09
Enanta Pharmaceuticals USD -23.54M 6.31M 2024-12
Exelixis USD 268.42M 20.01M 2026-09
Gilead Sciences USD 3.85B 1.17B 2026-06
Halozyme Therapeutics USD -60.68M 3.04M 2026-09
Incyte USD -707.47M 1.41B 2026-09
Ionis Pharmaceuticals USD -130M 27.71M 2026-09
Nektar Therapeutics USD -38.26M 19.17M 2026-03
Neurocrine Biosciences USD 343M 123.1M 2026-09
Pfizer USD 4.85B 5.03B 2026-09
Prothena USD -18.69M 44.48M 2026-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Repligen USD 24.31M 3.18M 2026-09
Rigel Pharmaceuticals USD 447K 1.52M 2024-06
Sarepta Therapeutics USD -9.04M 22.33M 2026-09
Teva Pharmaceutical Industries USD 1.19B 954M 2026-09
Ultragenyx Pharmaceutical USD -110M 35M 2026-09
Vertex Pharmaceuticals USD 1.26B 11.3M 2026-09